Mary J. Kuhn, Executive VP, Operations at Talecris Biotherapeutics Holdings Corp. (TLCR), sold 54,697 shares at $23.08 ($1.3M) on 2011-01-03, disclosed to the SEC on 2011-01-04.
Scheduled sale ($1.3M) by Executive VP, Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TLCR | SELL | 2010-10-04 | $1.1M | — | Filing → |
| TLCR | SELL | 2010-09-16 | $759K | — | Filing → |
| TLCR | SELL | 2010-09-03 | $1.0M | — | Filing → |